Leveraging Virtual Reality Technology for Acute Pain
Virtual reality technology may be useful in such areas as exposure therapy and pain management.
Acute Pain
Use by Paramedics of Intranasal Ketamine Plus Nitrous Oxide May Alleviate Acute Pain
The addition of intranasal ketamine, administered by paramedics, to usual treatment with nitrous oxide was found to alleviate acute pain and improve comfort within 30 minutes.
IV Hydromorphone Superior to IV Lidocaine for Abdominal Pain in the ED
Intravenous (IV) administration of hydromorphone may be more effective than IV lidocaine in alleviating abdominal pain in the emergency department.
Robust Evidence Supports Analgesic, Antihyperalgesic Properties of Ketamine
There is solid evidence supporting the notion that ketamine may have analgesic and antihyperalgesic properties.
Predicting Time to Pain Resolution, Recovery, and Opioid Cessation After Surgery
In surgical patients, time to pain resolution, complete recovery from surgery, and opioid cessation were found to be predicted by the worst pain occurring 10 days after surgery.
Lancet Article Series on Postoperative Pain Management Practices
A series of 3 articles published in the Lancet is dedicated to highlighting the nature of current postsurgical pain management practices, including the use of peri- and postoperative opioids, that are thought to play a part in driving the opioid crisis.
IV Lidocaine/Ketorolac Combination Superior to Lidocaine Alone for Renal Colic Pain
A combination of intravenous lidocaine and ketorolac was found to be superior to IV lidocaine alone and comparable with IV ketorolac alone for alleviating suspected renal colic pain.
Second Complete Response Letter Issued for IV Meloxicam
The Food and Drug Administration (FDA) has sent a second Complete Response Letter to Recro Pharma concerning their New Drug Application for intravenous meloxicam.
Four-to-Seven-Day Opioid Prescription Likely Sufficient for Acute Pain Treatment
An opioid supply for seven or fewer days might be sufficient for most patients seen in primary care settings for acute pain who appear to need opioid analgesics.
Authorized Generic of Flector Patch Now Available From Teva
An authorized generic of Flector Patch (diclofenac epolamine topical patch) has been made available by Teva Pharmaceuticals for the topical treatment of acute pain due to minor strains, sprains, and contusions.
Next post in Acute Pain
